perfluorobutane: Clinical Trials

7 trials of perfluorobutane, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 3 Phase 1, 2 Not applicable, 1 Early Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Not applicable2Completed 2
Early Phase 11Completed 1
Phase 21Completed 1
Phase 31Completed 1

Follow perfluorobutane: new trials by email Literature Review of perfluorobutane trials Research Report on perfluorobutane

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC
Perfluorobutane - Hepatocellular Carcinoma, Microwave Ablation
Not applicableCompletedInstitute of Liver and Biliary Sciences, India212021-10-012021-12-21
Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer
Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA), Contrast-Enhanced Ultrasound, Fine-Needle Aspiration - Esophagus
Early Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University352018-09-062025-05-18
Superb Microvascular Imaging in Focal Nodular Hyperplasia
Sonazoid, Superb-Microvascular imaging - Focal Nodular Hyperplasia
Not applicableCompletedSamsung Medical Center622016-05-012019-12-17
Contrast Ultrasound Detection of Sentinel Lymph Nodes
Sonazoid; Perflubutane for Injection - Breast Cancer
Phase 1 / Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University982016-01-012023-01-23
A Study to Evaluate Pharmacokinetics of Sonazoid™ Following Intravenous Bolus Injection in Healthy Volunteers
Sonazoid™ - Healthy
Phase 1CompletedGE Healthcare162014-10-202017-11-14
Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study
AI-700 - Coronary Artery Disease
Phase 3CompletedAcusphere392006-11-012008-05-01
Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF
AI-700 - Congestive Heart Failure, Chronic Obstructive Pulmonary Disease
Phase 1CompletedAcusphere2004-08-012006-10-23

Conditions studied

Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Coronary Artery Disease (1)  ·  Focal Nodular Hyperplasia (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Acusphere (2)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (2)  ·  GE Healthcare (1)  ·  Institute of Liver and Biliary Sciences, India (1)  ·  Samsung Medical Center (1)

Countries

United States (4)  ·  China (1)  ·  India (1)  ·  South Korea (1)

Top investigators

Amar Mukund, MBBS, MD (1)  ·  Flemming Forsberg, PhD (1)  ·  Francois Tranquart, MD, PhD (1)  ·  Ji-Bin Liu, MD (1)  ·  Woo Kyoung Woo, M.D. (1)

Results publications

PMID 35842563

NIH funding

R01CA172336 (1), R21CA218946 (1)